Evidence map›Paper›PMID 28984583›Full record

ArticleJournal of Alzheimer's disease : JAD2017

Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.

Miranda Tuwaig, Mélissa Savard, Benoît Jutras, Judes Poirier, D Louis Collins, Pedro Rosa-Neto, David Fontaine, John C S Breitner, PREVENT-AD Research Group

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Sensory Loss and Risk of Dementia.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2024
    Review
  13. Article
  14. Association of Central Auditory Processing Dysfunction With Preclinical Alzheimer's Disease.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2023
    Observational
  15. Article
  16. The hearing hippocampus.Progress in neurobiology · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Miranda TuwaigDouglas Mental Health University Institute, Montreal, QC, Canada.
Mélissa SavardDouglas Mental Health University Institute, Montreal, QC, Canada.
Benoît JutrasSainte-Justine Hospital Pediatric Research Centre, Montreal, QC, Canada.
Judes PoirierDouglas Mental Health University Institute, Montreal, QC, Canada.
D Louis CollinsDouglas Mental Health University Institute, Montreal, QC, Canada.
Pedro Rosa-NetoDouglas Mental Health University Institute, Montreal, QC, Canada.
David FontaineDouglas Mental Health University Institute, Montreal, QC, Canada.
John C S BreitnerDouglas Mental Health University Institute, Montreal, QC, Canada.
PREVENT-AD Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prevention of dementia due to Alzheimer's disease (d/AD) requires interventions that slow the disease process prior to symptom onset. To develop such interventions, one needs metrics that assess pre-symptomatic disease progression. Familiar measures of progression include cerebrospinal fluid (CSF) biochemical and imaging analyses, as well as cognitive testing. Changes in the latter can sometimes be difficult to distinguish from effects of "normal" aging. A different approach involves testing of "central auditory processing" (CAP), which enables comprehension of auditory stimuli amidst a distracting background (e.g., conversation in a noisy bar or restaurant). Such comprehension is often impaired in d/AD. Similarly, effortful or diminished auditory comprehension is sometimes reported by cognitively healthy elders, raising the possibility that CAP deficit may be a marker of pre-symptomatic AD. In 187 cognitively and physically healthy members of the aging, AD family history-positive PREVENT-AD cohort, we therefore evaluated whether CAP deficits were associated with known markers of AD neurodegeneration. Such markers included CSF tau concentrations and magnetic resonance imaging volumetric and cortical thickness measures in key AD-related regions. Adjusting for age, sex, education, pure-tone hearing, and APOEɛ4 status, we observed a persistent relationship between CAP scores and CSF tau levels, entorhinal and hippocampal cortex volumes, cortical thickness, and deficits in cognition (Repeatable Battery for Assessment of Neuropsychological Status total score, and several of its index scales). These cross-sectional observations suggest that CAP may serve as a novel metric for pre-symptomatic AD pathogenesis. They are therefore being followed up longitudinally with larger samples.

Indexed as

Auditory PerceptionAge FactorsAlzheimer DiseaseApolipoprotein E4Audiometry, Pure-ToneBiomarkersCerebral CortexCohort StudiesCross-Sectional StudiesEducational StatusFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsApolipoprotein E4BiomarkersMAPT protein, humantau ProteinsBiomarkerscentral auditory processing disordercognitive functionpre-clinical Alzheimer’s diseasepreventionsensorineural assessment

Identifiers

PMID28984583
PMCPMC5757649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.